Adding Magnesium Sulfate to Combined Pecto-Intercostal & Serratus Anterior Planes Block on Post-operative Analgesia in Patients Undergoing Modified Radical Mastectomy

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexFemale
Age30-75
SponsorSouth Egypt Cancer Institute

About this trial

Here, in our study, we intend to compare the analgesic efficacy of magnesium sulfate as an adjuvant to local anesthetics added to the Pecto-Intercostal Fascial Block (PIFB) vs the Serratus Anterior Plane Block (SAPB) in patients undergoing modified radical mastectomy.

Study Endpoints Primary Endpoints: Total intravenous opioid consumption during the first 24 hours following surgery. Secondary Endpoints: Postoperative analgesia, 24 hours after surgery, assessed using the Visual Analog Scale (VAS) and time to first analgesic request.

Eligibility criteria

Qualifiers

Female patients aged 30 to 75 years diagnosed with non-metastatic breast cancer and scheduled for modified radical mastectomy.

ASA, I-III and NYHA, I-II.

Written informed consent.

Disqualifiers

ASA physical status >III and NYHA >II,

body mass index >40 kg/m2,

pregnant women,

Patients with organ failure or coagulation disorders.

Trial design

Treatments tested in this trial

  • combined Pecto-Intercostal- Serratus anterior fascial planes Block

Treatment groups

100 Participants
are divided into 2 treatment groups

Locations

This trial has no locations

Sponsors and collaborators

South Egypt Cancer Institute

Lead sponsor

Assiut University

Collaborator